Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023856975> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2023856975 endingPage "2587" @default.
- W2023856975 startingPage "2579" @default.
- W2023856975 abstract "Human rhinovirus, the chief cause of the common cold, contains a positive-sense strand of RNA which is translated into a large polyprotein in infected cells. Cleavage of the latter to produce the mature viral proteins required for replication is catalyzed in large part by a virally encoded cysteine proteinase (3Cpro) which is highly selective for -Q approximately GP- cleavage sites. We synthesized peptidyl derivatives of vinylogous glutamine or methionine sulfone esters (e.g., Boc-Val-Leu-Phe-vGln-OR: R = Me, 1; R = Et, 2) and evaluated them as inhibitors of HRV-14 3C protease (3Cpro). Compounds 1 and 2 and several related tetra- and pentapeptide analogues rapidly inactivated 3Cpro with submicromolar IC50 values. Electrospray mass spectrometry confirmed the expected 1:1 stoichiometry of 3Cpro inactivation by 1, 2, and several other analogues. Compound 2 also proved to be useful for active site titration of 3Cpro, which has not been possible heretofore because of the lack of a suitable reagent. In contrast to 1, 2, and congeners, peptidyl Michael acceptors lacking a P4 residue have greatly reduced or negligible activity against 3Cpro, consistent with previously established structure-activity relationships for 3Cpro substrates. Hydrolysis of the P1 vinylogous glutamine ester to a carboxylic acid also decreased inhibitory activity considerably, consistent with the decreased reactivity of acrylic acids vs acrylic esters as Michael acceptors. Incorporating a vinylogous methionine sulfone ester in place of the corresponding glutamine derivative in 1 also reduced activity substantially. Compounds 1 and 2 and several of their analogues inhibited HRV replication in cell culture by 50% at low micromolar concentrations while showing little or no evidence of cytotoxicity at 10-fold higher concentrations. Peptidyl Michael acceptors and their analogues may prove useful as therapeutic agents for pathologies involving cysteine proteinase enzymes." @default.
- W2023856975 created "2016-06-24" @default.
- W2023856975 creator A5005758410 @default.
- W2023856975 creator A5007930653 @default.
- W2023856975 creator A5010290503 @default.
- W2023856975 creator A5013632328 @default.
- W2023856975 creator A5041626322 @default.
- W2023856975 creator A5047234096 @default.
- W2023856975 creator A5072297547 @default.
- W2023856975 creator A5088422127 @default.
- W2023856975 date "1998-06-16" @default.
- W2023856975 modified "2023-10-16" @default.
- W2023856975 title "Synthesis and Evaluation of Peptidyl Michael Acceptors That Inactivate Human Rhinovirus 3C Protease and Inhibit Virus Replication" @default.
- W2023856975 cites W1976683819 @default.
- W2023856975 cites W1989792394 @default.
- W2023856975 cites W2017792639 @default.
- W2023856975 cites W2034258157 @default.
- W2023856975 cites W2040910611 @default.
- W2023856975 cites W2045509933 @default.
- W2023856975 cites W2068974401 @default.
- W2023856975 cites W2083736746 @default.
- W2023856975 cites W2095066895 @default.
- W2023856975 cites W2124026826 @default.
- W2023856975 cites W2145365999 @default.
- W2023856975 doi "https://doi.org/10.1021/jm980114+" @default.
- W2023856975 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9651162" @default.
- W2023856975 hasPublicationYear "1998" @default.
- W2023856975 type Work @default.
- W2023856975 sameAs 2023856975 @default.
- W2023856975 citedByCount "49" @default.
- W2023856975 countsByYear W20238569752012 @default.
- W2023856975 countsByYear W20238569752013 @default.
- W2023856975 countsByYear W20238569752014 @default.
- W2023856975 countsByYear W20238569752015 @default.
- W2023856975 countsByYear W20238569752016 @default.
- W2023856975 countsByYear W20238569752017 @default.
- W2023856975 countsByYear W20238569752022 @default.
- W2023856975 countsByYear W20238569752023 @default.
- W2023856975 crossrefType "journal-article" @default.
- W2023856975 hasAuthorship W2023856975A5005758410 @default.
- W2023856975 hasAuthorship W2023856975A5007930653 @default.
- W2023856975 hasAuthorship W2023856975A5010290503 @default.
- W2023856975 hasAuthorship W2023856975A5013632328 @default.
- W2023856975 hasAuthorship W2023856975A5041626322 @default.
- W2023856975 hasAuthorship W2023856975A5047234096 @default.
- W2023856975 hasAuthorship W2023856975A5072297547 @default.
- W2023856975 hasAuthorship W2023856975A5088422127 @default.
- W2023856975 hasConcept C181199279 @default.
- W2023856975 hasConcept C185592680 @default.
- W2023856975 hasConcept C55493867 @default.
- W2023856975 hasConcept C71240020 @default.
- W2023856975 hasConceptScore W2023856975C181199279 @default.
- W2023856975 hasConceptScore W2023856975C185592680 @default.
- W2023856975 hasConceptScore W2023856975C55493867 @default.
- W2023856975 hasConceptScore W2023856975C71240020 @default.
- W2023856975 hasIssue "14" @default.
- W2023856975 hasLocation W20238569751 @default.
- W2023856975 hasLocation W20238569752 @default.
- W2023856975 hasOpenAccess W2023856975 @default.
- W2023856975 hasPrimaryLocation W20238569751 @default.
- W2023856975 hasRelatedWork W1164537646 @default.
- W2023856975 hasRelatedWork W1850986032 @default.
- W2023856975 hasRelatedWork W1968721630 @default.
- W2023856975 hasRelatedWork W2019529003 @default.
- W2023856975 hasRelatedWork W2029732200 @default.
- W2023856975 hasRelatedWork W2065079376 @default.
- W2023856975 hasRelatedWork W2080203695 @default.
- W2023856975 hasRelatedWork W2084240653 @default.
- W2023856975 hasRelatedWork W2115477213 @default.
- W2023856975 hasRelatedWork W4242974861 @default.
- W2023856975 hasVolume "41" @default.
- W2023856975 isParatext "false" @default.
- W2023856975 isRetracted "false" @default.
- W2023856975 magId "2023856975" @default.
- W2023856975 workType "article" @default.